Evidence map›Paper›PMID 41254176›Full record

ArticlePediatric research2026

A national strategic framework for developing medical devices for children.

Geoffrey L Rosenthal, Vasum Peiris, Erika Torjusen, Tara Federici, Suzanne B Schwartz, Linda J Ricci, Jonathan M Davis, SHIP-MD Consortium

Abstract read
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Geoffrey L Rosenthal *UVA Health Children's, University of Virginia School of Medicine, Charlottesville, VA, USA.
Vasum Peiris *The US Food and Drug Administration, Center for Devices and Radiological Health, White Oak, MD, USA.
Erika TorjusenThe US Food and Drug Administration, Office of Orphan Products Development, White Oak, MD, USA.
Tara FedericiAdvaMed-Advanced Medical Technology Association, Washington, DC, USA.
Suzanne B SchwartzThe US Food and Drug Administration, Center for Devices and Radiological Health, White Oak, MD, USA.
Linda J RicciThe US Food and Drug Administration, Center for Devices and Radiological Health, White Oak, MD, USA.
Jonathan M DavisDivision of Newborn Medicine, Tufts Medical Center, Boston, MA, USA. jonathan.davis1@tuftsmedicine.org.
SHIP-MD Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite widespread and urgent therapeutic need, less than a quarter of new medical devices are developed and approved specifically for children, leaving this growing population with limited treatment options. The System of Hospitals for Innovation in Pediatrics - Medical Devices (SHIP-MD) framework is an initiative involving many key participants from both the private and public sectors which was developed to address this challenge. SHIP-MD is a multidisciplinary effort with a primary aim to improve the quantity and quality of medical devices that are specifically indicated for use in pediatric populations. The program centers on five priority areas: 1) finance (organizational and operating models; device development funding), 2) hospitals (criteria that hospitals must satisfy in order to participate), 3) navigation (on-boarding of innovators, coordination and management of evidence generation), 4) regulation (refining and optimizing current regulatory processes, recommending new regulatory options), and 5) reimbursement (harmonizing regulatory/reimbursement processes, expediting unique coding to optimize reimbursement, enhancing payments/coverage). SHIP-MD represents a path forward to addressing a long-standing public health matter. The developed framework is feasible and actionable with steps presently being taken to operationalize this national approach. IMPACT: Pediatric device development faces significant challenges including economic disincentives, ethical concerns, and absence of robust advocacy. Potential solutions involve leveraging public-private partnerships to drive innovation. The System of Hospitals for Innovation in Pediatrics - Medical Devices (SHIP-MD) is an initiative involving the private and public sectors which was conceived to address these multiple challenges and represents an important path forward. The developed framework is feasible and actionable with steps presently being taken to operationalize this national approach. Less than a quarter of new medical devices are developed and authorized specifically for children. Pediatric device development faces significant challenges such as complex funding/reimbursement models and regulatory frameworks. Potential solutions involve leveraging unique public-private partnerships which have been proposed through the System of Hospitals for Innovation in Pediatrics - Medical Devices (SHIP-MD) framework.

Indexed as

Equipment and SuppliesPediatricsChildEquipment DesignHumansUnited States

Identifiers

PMID41254176
PMCPMC13485687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.